The global white biotech market size is anticipated to expand at a robust CAGR during the forecast period, 2021-2028. The growth of the market is attributed to rising awareness about the white biotechnology benefits such as low waste generation and reduced manufacturing cost.
White biotechnology is used in industries wherein biocatalyst such as microorganisms and enzymes plays a key role. This biotechnology is solely applied to the industry to replace polluting technologies with clean ones. This technology uses living cells from molds, bacteria, plants, and yeast to synthesize the easily degradable products, which need less energy and produces fewer by-product wastes.
Bacterial enzymes have been used widely in food manufacturing and as an active ingredient in washing powders to reduce the amount of artificial surfactants. Moreover, transgenic Escherichia coli are used to produce human insulin in large-scale fermentation tanks.
White biotechnology has been increasingly utilized chemical, textile, food, packaging and health care industries, providing opportunities for industry players. Policy makers are increasingly showing interest in this nascent technology, as it is helping in creating sustainable products.
The report on the global white biotech market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|Report Title||White Biotech Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast|
|Segmentation||Types (Biofuels, Biomaterials, Biochemicals, and Industrial Enzymes) and Applications (Chemicals, Pharmaceuticals, Food & Beverages, Feed, and Others)|
|Regional Scope||Asia Pacific, North America, Latin America, Europe, and Middle East & Africa|
|Report Coverage||Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast|
|Key Players Covered in the Report||Archer Daniels Midland Company, BASF SE, Cargill Inc., Corbion N.V., Koninklijke DSM N.V, DuPont, Lesaffre, Novozymes, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Hologic Inc., iCAD Inc., InVivo Corporation, McKesson Corporation, Merge Healthcare Incorporated (IBM), Philips Healthcare, Samsung Medison Co. Ltd., Siemens Healthcare, and Toshiba Medical Systems Corporation|
Biofuel segment to account a major market share
Based on types, the market is divided into biofuels, biomaterials, biochemicals, and industrial enzymes. The biofuels segment is anticipated to account for a key share during the forecast period. Biofuels are used as a gasoline additive to improve the octane rating of a vehicle, which is used to reduce the level of particulates such as hydrocarbon. However, the biochemicals segment is expected to expand at a healthy CAGR during the forecast period. Ongoing technological advancement in polymer development technology is expected to create lucrative opportunities for the segment.
Pharmaceuticals segment to grow at a rapid pace
Based on applications, the market is divided into chemicals, pharmaceuticals, food and beverages, feed, and others. The pharmaceuticals segment is anticipated to grow at a rapid rate during the forecast period. Rising technology use in the manufacturing of antibodies for cancer treatment is driving the segment growth. Moreover, enzymes used in this process enable the production of chiral compounds and other intermediates such as active pharmaceutical ingredients (API). However, the food & beverages segment is expected to expand at a healthy CAGR in the projected timeline.
North America to account a large market share
On the basis of regions, the market is segregated into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is expected to account for a large market share during the forecast period. Increasing number of funds by the government for the R&D activities and rising demand for green products and chemicals from consumers are the key factors that are driving the regional market growth. However, the market in Europe is expected to register a substantial growth rate in the white biotech market.
Segments Covered in the Report
The global white biotech market has been segmented on the basis of
The major players of the market are Archer Daniels Midland Company, BASF SE, Cargill Inc., Corbion N.V., Koninklijke DSM N.V, DuPont, Lesaffre, Novozymes, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Hologic Inc., iCAD Inc., InVivo Corporation, McKesson Corporation, Merge Healthcare Incorporated (IBM), Philips Healthcare, Samsung Medison Co. Ltd., Siemens Healthcare, and Toshiba Medical Systems Corporation.
Companies are focusing on innovation, partnerships, and acquisitions to expand their market share.
Some other reports from this category!